Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease
AUTOR(ES)
Taveira, A.T.A., Pereira, F.A., Fernandes, M.I.M., Sawamura, R., Nogueira-Barbosa, M.H., Paula, F.J.A.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
2010-11
RESUMO
Bone mass loss is a major complication of chronic cholestatic liver disease (CCD). However, the long-term impact of CCD on bone mass acquisition is unknown. We longitudinally assessed bone mineral density (BMD) and factors involved in bone remodeling in 9 children and adolescents with CCD Child-Pugh A (5 boys/4 girls) and in 13 controls (6 boys/7 girls). The groups were evaluated twice, at baseline (T0) and after 3 years (T1), when osteocalcin, deoxypyridinoline, 25-hydroxyvitamin-D, parathyroid hormone, insulin-like growth factor-I (IGF-I), and BMD (L1-L4, proximal femur and total body) were determined. Serum levels of receptor activator for nuclear factor kB ligand (RANKL) and osteoprotegerin were measured only at T1. Lumbar spine BMD was reanalyzed twice: after adjustment for bone age and to compensate for the height factor. Volumetric density was also estimated mathematically in L2-L4. The BMD of L1-L4 was lower in the CCD group (Z-score at T0: control = -1.2 ± 0.8 vs CCD = -2.2 ± 1.4, P < 0.05; T1: control = -0.7 ± 0.8 vs CCD = -2.1 ± 1.1, P < 0.05). Osteocalcin and deoxypyridinoline were similar for the two groups. The CCD group presented lower IGF-I (Z-score at T1: control = 1.4 ± 2.8 vs CCD = -1.5 ± 1.0, P < 0.05) and RANKL (control = 0.465 ± 0.275 vs CCD = 0.195 ± 0.250 pM, P < 0.05) than control. Children with compensated CCD Child-Pugh A showed early impairment of bone acquisition, with the impact being more severe in an initial phase and then tapering in a slowly progressive way. Reduction in endocrine IGF-I has a crucial role in this process.
Documentos Relacionados
- Portal lymphadenopathy associated with lipofuscin in chronic cholestatic liver disease.
- Evaluation of carotid intima-media thickness and factors associated with cardiovascular disease in children and adolescents with chronic kidney disease
- Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents
- Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
- Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease